ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1396

Can 3 0-10 Physician Visual Analog Scales (VAS) to Assess Levels of Inflammation, Damage and Distress Offer Comprehensive Quantitative Data That May be As Informative As Detailed, Formal Swollen and Tender Joint Counts?

MJ Bergman1 and Theodore Pincus2, 1Drexel University College of Medicine, Philadelphia, PA, 2Rheumatology, Rush University Medical Center, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Inflammation

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Management of patients with rheumatoid arthritis (RA) remains primarily according to a patient history and physical examination, unlike in many other chronic diseases, in which a “gold standard” biomarker, such as a laboratory test provides the primary basis for clinical management. A need for quantitative measures has led to a count of tender and swollen joints. A formal joint count is standard in clinical trials and clinical research, but not at most patient visits. Perhaps this phenomenon suggests that a joint examination without a formal quantitative joint count may be adequate, e.g., it matters considerably whether a patient has, say, 2 vs 12 swollen joints, but not necessarily whether the patient has 1 vs 2 or 11 vs 12 swollen joints. Furthermore, joint counts have relatively poor test-retest reliability, and can be affected by phenomena other than inflammatory activity, such as joint damage and/or distress. An alternative approach to quantitate a clinical encounter involves 3 physician visual analog scales (VAS) for inflammation, damage and distress to supplement a physician global assessment, as analyzed here.

Methods: At one private practice rheumatology site, all patients complete a patient self-report MDHAQ/RAPID3 at each visit. The rheumatologist performs a formal 28-joint count of tender (TJC) and swollen (SJC) joints, and then completes four 0-10 VAS, for overall global assessment, inflammation, damage, and distress. A random visit of 259 RA patients was studied for mean values, and correlations of the 4 physician VASs with SJC and TJC. Because correlations may be artefactually elevated if many patients have a value for a zero for the two variables compared, correlations also were calculated of patients whose SJC was >1.

Results: Mean values for the 0-10 VASs were 2.09 for physician global assessment, 2.50 for inflammation, 1.47 for damage and 0.74 for distress, as well as 4.17 for patient global assessment (Table). Mean SJC 28 was 5.15, and TJ C 28 2.54. SJC was correlated at significantly higher levels with the inflammation VAS, r=0.766 than the damage VAS, r=0.235, or distress VAS, r=0.030. In patients only with SJC >1, the correlation of SJC with the inflammation VAS was somewhat lower, r=0.688, but remained significantly higher than other correlations with physician VAS. The correlation of TJC was similar for overall global, inflammation and distress. The 4 VAS required about 15 seconds to complete vs about 90 seconds for a 28 joint count.

Measure

Mean value±SD

Correlation with SJC

Correlation with TJC

Correlation with SJC>1

Correlation with TJC>1

Physician global assessment

VAS

2.09±2.18

0.415

0.372

0.333

0.338

Inflammation

VAS

2.50±2.04

0.766

0.389

0.688

0.344

Damage VAS

1.47±1.81

0.235

0.062

0.174

0.016

Distress VAS

0.74±1.55

0.030

0.345

0.017

0.272

SJC28

5.15±5.32

—–

0.386

—–

0.411

TJC28

2.54±4.95

0.386

—-

0.411

—–

Patient global assessment

VAS

4.17±2.83

0.312

0.369

0.241

0.350

VAS=visual analog scale, SJC= swollen joint count, TJC= tender joint count

Conclusion: 3 physician VAS for inflammation, damage and distress may provide a useful tool to document a physician assessment of patient status and the rationale for clinical decisions, e.g., not escalating anti-inflammatory therapy in a patient with high RA index score who does not have high scores for inflammation but rather high scores for damage and/or distress.


Disclosure: M. Bergman, None; T. Pincus, Theodore Pincus, 7.

To cite this abstract in AMA style:

Bergman M, Pincus T. Can 3 0-10 Physician Visual Analog Scales (VAS) to Assess Levels of Inflammation, Damage and Distress Offer Comprehensive Quantitative Data That May be As Informative As Detailed, Formal Swollen and Tender Joint Counts? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/can-3-0-10-physician-visual-analog-scales-vas-to-assess-levels-of-inflammation-damage-and-distress-offer-comprehensive-quantitative-data-that-may-be-as-informative-as-detailed-formal-swollen-and-t/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-3-0-10-physician-visual-analog-scales-vas-to-assess-levels-of-inflammation-damage-and-distress-offer-comprehensive-quantitative-data-that-may-be-as-informative-as-detailed-formal-swollen-and-t/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology